HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

More Information on Medical Education

Letter About the ACGME's Draft Principles to Guide Industry and Education Interactions

August 23, 2002

Patricia M. Surdyk, Ph.D.
Senior Project Manager
Accreditation Council for Graduate Medical Education
515 N. State Street
Suite 2000
Chicago, IL 60610

Dear Dr. Surdyk:

Cop out. There is no other way to describe the ACGME draft Principles to Guide the Relationship between Graduate Medical Education and Industry. The draft Principles are an at-times eloquent description of the massive conflicts that attend the growing relationship between industry and medical education programs. But when it comes time for the draft Principles to actually delineate what is and is not acceptable, the raison d’etre for these Principles, the draft document simply evades the issue.

The essence of the cop out appears on page 5, line 154:

Programs and sponsoring institutions must determine through policy, which contacts, if any, between residents and industry representatives may be suitable, and exclude occasions in which involvement by industry representatives or promotion of industry products is inappropriate.

Actually, the primary purpose of this document should have been to determine what those policies should include. Instead, the document offers the weakest possible recommendation: that someone else should come up with the policies. Of course, this implicitly allows these policies to vary from location to location and does not even establish a floor for acceptable policies.

Elsewhere the document is equally vague. On page 6, line 170, the ACGME suggests that residents learn "how promotional activities can influence judgment in prescribing decisions and research activities." What is really needed is to school residents in how to resist the largesse and sometimes misleading representations of industry. On line 185, the Guideline states that "These policies must clarify the differences between education and promotion." A more useful Principle would actually outline on what basis such a distinction might actually be made, particularly because many items provided by pharmaceutical companies are primarily promotional, rather than educational (Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med. 1996;11:575-83.). Similarly, the admonition that "Resident curricula should include discussion and reflection on managing encounters with industry representatives" is very weak and lacking in any specificity.

The draft document concludes by stating that "inappropriate activities must not be allowed to continue where they exist." Yet the document has provided no guidance whatsoever on what these inappropriate activities might be. Given the strong case that the draft Principles have made for the corrupting influence of industry, we believe that it is most in the interests of patients for residents to simply be precluded from interacting with industry. This means no industry-sponsored free lunches, no samples, no dinners, no movies, no concert tickets, no presence in the clinics or wards, no detailing, etc. Anything less will make the ACGME’s purported concern about the "irreconcilable difference" between the responsibilities of industry (to stockholders) and physicians (to patients) seem hollow.

Yours sincerely,

Peter Lurie, M.D., M.P.H.
Deputy Director

Sidney M. Wolfe, M.D.
Director
Public Citizen’s Health Research Group

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.